Daniel Olive
30Patents
6h-index
41Co-inventors
69Inventor score
Filing activity: Jan 28, 1993 → Oct 2, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8741295B2 | PD-1 antibodies and PD-L1 antibodies and uses thereof | Chemistry; Metallurgy | 56 | Active |
| US6739284B1 | Hummingbird feeder having removable vessel unit | Human Necessities | 45 | Expired |
| US5330285A | Apparatus for deflating tires of moving vehicles | Fixed Constructions | 39 | Expired |
| US9376493B2 | Antibodies directed against ICOS and uses thereof | Chemistry; Metallurgy | 22 | Active |
| US7723482B2 | Anti-CD28 antibody | Chemistry; Metallurgy | 17 | Expired |
| US9243052B2 | Method for treating and diagnosing hematologic malignancies | Physics | 11 | Active |
| US9676852B2 | Antibodies directed against ICOS and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US9637546B2 | PD-1 antibodies and PD-L1 antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US9975950B2 | Antibodies directed against ICOS and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US9695247B2 | Antibodies directed against ICOS for treating graft-versus-host disease | Chemistry; Metallurgy | 2 | Active |
| US5762933A | Method for preventing and treating graft failure in a human patient using a monoclonal antibody specific for leucocyte functional antigen LFA-1 | Human Necessities | 2 | Expired |
| US10716838B2 | Anti-CD277 antibodies | Chemistry; Metallurgy | 2 | Active |
| US8318166B2 | Ligands of HVEM for treating hematologic malignancies | Chemistry; Metallurgy | 1 | Active |
| US10745482B2 | Antibodies directed against ICOS and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10633446B2 | Antibodies directed against ICOS and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12049500B2 | Anti-nectin-4-antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10675357B2 | Antibodies having specificity to nectin-4 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11904004B2 | Anti-CD277 antibodies | Chemistry; Metallurgy | 0 | Active |
| US12247075B2 | BTN3A binding proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10273306B2 | Antibodies directed against ICOS for treating graft-versus-host disease | Chemistry; Metallurgy | 0 | Active |
| US11180556B2 | Antibodies directed against ICOS and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11987631B2 | Anti-BTN3A antibodies and their use in treating cancer or infectious disorders | Chemistry; Metallurgy | 0 | Active |
| US11572409B2 | Antibodies having specificity for BTN2 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11945871B2 | Anti-BTN3A antibodies and their use in treating cancer or infectious disorders | Chemistry; Metallurgy | 0 | Active |
| US12258400B2 | Antibodies having specificity for BTN2 and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.